According to Shen et al., δ-TT has the potential to treat nasopharyngeal carcinoma by inducing apoptosis in CNE3 nasopharyngeal carcinoma cells through the caspase-3 signaling [27]. This evidence concerns the gene CASP3 and nasopharyngeal carcinoma.